Skip to main content
SpringerLink
Log in

Gastric and Small Bowel Tumors

  • Chapter
  • First Online:
Gastrointestinal Malignancies

Part of the book series: Cancer Treatment and Research ((CTAR))

Abstract

The incidence of gastric adenocarcinoma has decreased in the United States over the past 70 years although it continues to have a poor prognosis. While radical resection was initially the primary treatment for adenocarcinoma of the stomach, systemic chemotherapy and radiation have been shown to play a role in prolonging survival in most patient populations. This chapter explores the evidence that guides treatment for gastric cancer today. It also discusses the treatment for gastrointestinal stromal tumors (GIST), and small bowel tumors. In addition to systemic therapies, this chapter explores the surgical management of gastric and small bowel tumors including the extent of the gastric lymph node dissection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62(1):10–29. doi:10.3322/caac.20138

    Article  PubMed  Google Scholar 

  2. Hundahl SA, Phillips JL, Menck HR (2000) The national cancer data base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer 88(4):921–932

    Article  CAS  PubMed  Google Scholar 

  3. Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta pathologica et microbiologica Scandinavica 64:31–49

    CAS  PubMed  Google Scholar 

  4. Ogimoto I, Shibata A, Fukuda K (2000) World Cancer Research Fund/American Institute of Cancer Research 1997 recommendations: applicability to digestive tract cancer in Japan. Cancer Causes Control CCC 11(1):9–23

    Article  CAS  PubMed  Google Scholar 

  5. Helicobacter, Cancer Collaborative Group (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49(3):347–353

    Google Scholar 

  6. Correa P (2003) Bacterial infections as a cause of cancer. J Natl Cancer Inst 95(7):E3

    Article  PubMed  Google Scholar 

  7. Peek RM Jr, Blaser MJ (2002) Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2(1):28–37. doi:10.1038/nrc703

    Article  CAS  PubMed  Google Scholar 

  8. La Vecchia C, Negri E, Franceschi S, Gentile A (1992) Family history and the risk of stomach and colorectal cancer. Cancer 70(1):50–55

    Article  PubMed  Google Scholar 

  9. Hansson LE, Nyren O, Bergstrom R, Wolk A, Lindgren A, Baron J, Adami HO (1994) Nutrients and gastric cancer risk. A population-based case-control study in Sweden. Int J Cancer J Int Du Cancer 57(5):638–644

    Google Scholar 

  10. Yalamarthi S, Witherspoon P, McCole D, Auld CD (2004) Missed diagnoses in patients with upper gastrointestinal cancers. Endoscopy 36(10):874–879. doi:10.1055/s-2004-825853

    Article  CAS  PubMed  Google Scholar 

  11. Takao M, Fukuda T, Iwanaga S, Hayashi K, Kusano H, Okudaira S (1998) Gastric cancer: evaluation of triphasic spiral CT and radiologic-pathologic correlation. J Comput Assist Tomogr 22(2):288–294

    Article  CAS  PubMed  Google Scholar 

  12. Davies J, Chalmers AG, Sue-Ling HM, May J, Miller GV, Martin IG, Johnston D (1997) Spiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging. Gut 41(3):314–319

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Messmann H, Schlottmann K (2001) Role of endoscopy in the staging of esophageal and gastric cancer. Semin Surg Oncol 20(2):78–81

    Article  CAS  PubMed  Google Scholar 

  14. Hundahl SA, Menck HR, Mansour EG, Winchester DP (1997) The National Cancer Data Base report on gastric carcinoma. Cancer 80(12):2333–2341

    Article  CAS  PubMed  Google Scholar 

  15. Maruyama K, Okabayashi K, Kinoshita T (1987) Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11(4):418–425

    Article  CAS  PubMed  Google Scholar 

  16. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79(9–10):1522–1530. doi:10.1038/sj.bjc.6690243

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I, Meyer S, Plukker JT, Van Elk P, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Dutch Gastric Cancer G (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340(12):908–914. doi:10.1056/NEJM199903253401202

    Article  CAS  PubMed  Google Scholar 

  18. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol Official J Am Soc Clin Oncol 22(11):2069–2077. doi:10.1200/JCO.2004.08.026

    Article  CAS  Google Scholar 

  19. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen JH, Li AF, Lui WY, Whang-Peng J (2006) Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7(4):309–315. doi:10.1016/S1470-2045(06)70623-4

    Article  CAS  PubMed  Google Scholar 

  20. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K, Japan Clinical Oncology G (2008) D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 359(5):453–462. doi:10.1056/NEJMoa0707035

    Article  CAS  PubMed  Google Scholar 

  21. Karpeh MS, Leon L, Klimstra D, Brennan MF (2000) Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients. Ann Surg 232(3):362–371

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Talamonti MS, Kim SP, Yao KA, Wayne JD, Feinglass J, Bennett CL, Rao S (2003) Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery 134(4):720–727; discussion 727-729. doi:10.1016/S0039

  23. Edge SBBD, Compton CC et al (2010) AJCC cancer staging manual, 7th edn. Springer, New York

    Google Scholar 

  24. Sano T, Kobori O, Muto T (1992) Lymph node metastasis from early gastric cancer: endoscopic resection of tumour. Brit J Surg 79(3):241–244

    Article  CAS  PubMed  Google Scholar 

  25. Uedo N, Iishi H, Tatsuta M, Ishihara R, Higashino K, Takeuchi Y, Imanaka K, Yamada T, Yamamoto S, Yamamoto S, Tsukuma H, Ishiguro S (2006) Longterm outcomes after endoscopic mucosal resection for early gastric cancer. Gastric Cancer Official J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc 9(2):88–92. doi:10.1007/s10120-005-0357-0

    Google Scholar 

  26. Manner H, Rabenstein T, May A, Pech O, Gossner L, Werk D, Manner N, Gunter E, Pohl J, Vieth M, Stolte M, Ell C (2009) Long-term results of endoscopic resection in early gastric cancer: the Western experience. Am J Gastroenterol 104(3):566–573. doi:10.1038/ajg.2008.151

    Article  PubMed  Google Scholar 

  27. The National Comprehensive Cancer Network Guidelines in Oncology. http://www.nccn.org. Accessed February 6 2014

  28. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, Participants MT (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1):11–20. doi:10.1056/NEJMoa055531

    Article  CAS  PubMed  Google Scholar 

  29. Ychou M, Boige V, Pignon JP, Conroy T, Bouche O, Lebreton G, Ducourtieux M, Bedenne L, Fabre JM, Saint-Aubert B, Geneve J, Lasser P, Rougier P (2011) Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol Official J Am Soc Clin Oncol 29(13):1715–1721. doi:10.1200/JCO.2010.33.0597

    Article  CAS  Google Scholar 

  30. Gunderson LL, Sosin H (1982) Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8(1):1–11

    Article  CAS  PubMed  Google Scholar 

  31. Lee J, Lim do H, Kim S, Park SH, Park JO, Park YS, Lim HY, Choi MG, Sohn TS, Noh JH, Bae JM, Ahn YC, Sohn I, Jung SH, Park CK, Kim KM, Kang WK (2012) Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol Official J Am Soc Clin Oncol 30(3):268–273. doi:10.1200/JCO.2011.39.1953

    Google Scholar 

  32. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345(10):725–730. doi:10.1056/NEJMoa010187

    Article  CAS  PubMed  Google Scholar 

  33. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K, Group A-G (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357(18):1810–1820. doi:10.1056/NEJMoa072252

    Google Scholar 

  34. Nilsson B, Bumming P, Meis-Kindblom JM, Oden A, Dortok A, Gustavsson B, Sablinska K, Kindblom LG (2005) Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era–a population-based study in western Sweden. Cancer 103(4):821–829. doi:10.1002/cncr.20862

    Article  PubMed  Google Scholar 

  35. Ng EH, Pollock RE, Munsell MF, Atkinson EN, Romsdahl MM (1992) Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg 215(1):68–77

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Corless CL, Fletcher JA, Heinrich MC (2004) Biology of gastrointestinal stromal tumors. J Clin Oncol Official J Am Soc Clin Oncol 22(18):3813–3825. doi:10.1200/JCO.2004.05.140

    Article  CAS  Google Scholar 

  37. Miettinen M, Sobin LH, Lasota J (2005) Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29(1):52–68

    Article  PubMed  Google Scholar 

  38. Chou FF, Eng HL, Sheen-Chen SM (1996) Smooth muscle tumors of the gastrointestinal tract: analysis of prognostic factors. Surgery 119(2):171–177

    Article  CAS  PubMed  Google Scholar 

  39. Dematteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, Blackstein ME, Blanke CD, von Mehren M, Brennan MF, Patel S, McCarter MD, Polikoff JA, Tan BR, Owzar K, American College of Surgeons Oncology Group Intergroup Adjuvant GST (2009) Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet 373(9669):1097–1104. doi:10.1016/S0140-6736(09)60500-6

    Google Scholar 

  40. Joensuu H, Eriksson M, Sundby Hall K, Hartmann JT, Pink D, Schutte J, Ramadori G, Hohenberger P, Duyster J, Al-Batran SE, Schlemmer M, Bauer S, Wardelmann E, Sarlomo-Rikala M, Nilsson B, Sihto H, Monge OR, Bono P, Kallio R, Vehtari A, Leinonen M, Alvegard T, Reichardt P (2012) One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA J Am Med Assoc 307(12):1265–1272. doi:10.1001/jama.2012.347

    Article  CAS  Google Scholar 

  41. Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65(1):5–29. doi:10.3322/caac.21254

    Article  PubMed  Google Scholar 

  42. Frost DB, Mercado PD, Tyrell JS (1994) Small bowel cancer: a 30-year review. Ann Surg Oncol 1(4):290–295

    Article  CAS  PubMed  Google Scholar 

  43. Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H, Corless CL, Debiec-Rychter M, DeMatteo RP, Ettinger DS, Fisher GA, Fletcher CD, Gronchi A, Hohenberger P, Hughes M, Joensuu H, Judson I, Le Cesne A, Maki RG, Morse M, Pappo AS, Pisters PW, Raut CP, Reichardt P, Tyler DS, Van den Abbeele AD, von Mehren M, Wayne JD, Zalcberg J, Force NT (2007) NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)–update of the NCCN clinical practice guidelines. J Natl Compr Cancer Network JNCCN 5 Suppl 2:S1–S29; quiz S30

    Google Scholar 

  44. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347(7):472–480. doi:10.1056/NEJMoa020461

    Article  CAS  PubMed  Google Scholar 

  45. Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS (2009) Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 249(1):63–71. doi:10.1097/SLA.0b013e31818e4641

    Article  PubMed  Google Scholar 

  46. Torres M, Matta E, Chinea B, Dueno MI, Martinez-Souss J, Ojeda A, Vega W, Toro DH (2003) Malignant tumors of the small intestine. J Clin Gastroenterol 37(5):372–380

    Article  PubMed  Google Scholar 

  47. de Mascarenhas-Saraiva MN, da Silva Araujo Lopes LM (2003) Small-bowel tumors diagnosed by wireless capsule endoscopy: report of five cases. Endoscopy 35(10):865–868. doi:10.1055/s-2003-42625

    Article  PubMed  Google Scholar 

  48. Lambert P, Minghini A, Pincus W, Kolm P, Perry RR (1996) Treatment and prognosis of primary malignant small bowel tumors. Am Surg 62(9):709–715

    CAS  PubMed  Google Scholar 

  49. Bakaeen FG, Murr MM, Sarr MG, Thompson GB, Farnell MB, Nagorney DM, Farley DR, van Heerden JA, Wiersema LM, Schleck CD, Donohue JH (2000) What prognostic factors are important in duodenal adenocarcinoma? Arch Surg 135(6):635–641; discussion 641-632

    Google Scholar 

  50. Gilligan CJ, Lawton GP, Tang LH, West AB, Modlin IM (1995) Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol 90(3):338–352

    CAS  PubMed  Google Scholar 

  51. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J (2004) Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 101(3):518–526. doi:10.1002/cncr.20404

    Article  PubMed  Google Scholar 

  52. Overman MJ, Hu CY, Wolff RA, Chang GJ (2010) Prognostic value of lymph node evaluation in small bowel adenocarcinoma: analysis of the surveillance, epidemiology, and end results database. Cancer 116(23):5374–5382. doi:10.1002/cncr.25324

    Article  PubMed  Google Scholar 

  53. Talamonti MS, Goetz LH, Rao S, Joehl RJ (2002) Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Arch Surg 137(5):564–570; discussion 570-561

    Google Scholar 

  54. Ito H, Perez A, Brooks DC, Osteen RT, Zinner MJ, Moore FD Jr, Ashley SW, Whang EE (2003) Surgical treatment of small bowel cancer: a 20-year single institution experience. J Gastrointest Surg Official J Soc Surg Aliment Tract 7(7):925–930

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, USA

    L. Mark Knab & Anthony Yang

Authors
  1. L. Mark Knab
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Mark Knab .

Editor information

Editors and Affiliations

  1. Department of Surgery, Northwestern University, Chicago, Illinois, USA

    David Bentrem

  2. Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA

    Al B. Benson

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Knab, L.M., Yang, A. (2016). Gastric and Small Bowel Tumors. In: Bentrem, D., Benson, A. (eds) Gastrointestinal Malignancies. Cancer Treatment and Research. Springer, Cham. https://doi.org/10.1007/978-3-319-34244-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-34244-3_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-34242-9

  • Online ISBN: 978-3-319-34244-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation